Abstract: An electronic device may include a first die that may include a first set of die contacts. The electronic device may include a second die that may include a second set of die contacts. The electronic device may include a bridge interconnect that may include a first set of bridge contacts and may include a second set of bridge contacts. The first set of bridge contacts may be directly coupled to the first set of die contacts (e.g., with an interconnecting material, such as solder). The second set of bridge contacts may be directly coupled to the second set of die contacts (e.g., with solder). The bridge interconnect may help facilitate electrical communication between the first die and the second die.

Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for controlling a remotely operated vehicle (ROV) for performing an underwater task. One apparatus includes a watertight housing; a mounting hardware that attaches the watertight housing to the ROV; one or more sensors in the watertight housing, the one or more sensors configured to generate sensor data that is associated with an underwater task; and one or more processors in the watertight housing, the one or more processors configured to: receive the sensor data from the one or more sensors; generate a navigation plan for the ROV using the sensor data; determine, using the navigation plan, control instructions configured to control the ROV to perform the underwater task; and provide the control instructions to an interface of the ROV configured to communicate with the apparatus.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: Embodiments relate to compiling neural network operations into tasks that may be performed in a streaming manner by a neural processor. In a streaming operation, a tensor is spatially partitioned, and tasks associated two or more layers of the neural network are performed simultaneously in an overlapping manner. To enable efficient memory usage during streaming operation, a subset of the tasks having completion times close in time are assigned to a same portion of memory in the neural processor during a compilation process. After the tasks assigned to the same portion of the memory is finished, the portion of the memory may be flushed to make space for subsequent tasks. Multiple tasks may also be coalesced into a single task to reduce the number of tasks and more efficiently perform the operations at the neural processor.

Abstract: A polymerization process includes contacting an ethylene feed containing ethylene monomers with a catalyst feed containing a hafnium-based or zirconium-based single-site catalyst in a solution so as to polymerize the ethylene monomers into long-chain branched high density polyethylene having on average a long-chain branch/polymer chain less than 10 and greater than 0.25. A polymerization composition includes ethylene; a hafnium-based or zirconium-based single-site catalyst; and a long-chain branched high density polyethylene polymerization product, where the long-chain branched high density polyethylene has on average a long-chain branch/polymer chain less than 10 and greater than 0.25; and where at least one of the ethylene, the catalyst, and the product is in solution.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Methods, systems, and devices for wireless communication are described. A wireless device may initiate a successive decoding process for an encoded code block received at the wireless device, and generate, using a successive decoder, one or more candidate paths for a first portion of the code block, where the first portion of the code block includes a first data portion and a first data check portion. The wireless device may then perform a checking function on respective first data portions for the one or more candidate paths using respective first data check portions, and determine whether to terminate the successive decoding process prior to completing decoding of the encoded code block based at least in part on determining whether the checking function for each of the one or more candidate paths for the first data portion has failed the checking function.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Disclosed embodiments concern a device for administering a xinafoate salt of N4-[(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]-2,4-pyrimidinediamine, or compositions thereof, and a method for making and using the device. Particular disclosed embodiments concern formulating the xinafoate salt for administration via the device.

Abstract: Methods, systems, and devices for wireless communication are described. A wireless device may initiate a successive decoding process for an encoded code block received at the wireless device, and generate, using a successive decoder, one or more candidate paths for a first portion of the code block, where the first portion of the code block includes a first data portion and a first data check portion. The wireless device may then perform a checking function on respective first data portions for the one or more candidate paths using respective first data check portions, and determine whether to terminate the successive decoding process prior to completing decoding of the encoded code block based at least in part on determining whether the checking function for each of the one or more candidate paths for the first data portion has failed the checking function.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Embodiments of topical formulations for administering compound I or a pharmaceutically acceptable salt or solvate thereof are disclosed. Embodiments of methods for using the topical formulations in the treatment of dermatological disorders such as cutaneous collagen vascular diseases, e.g., cutaneous lupus, also are disclosed.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.